Cardiology Research and Practice / 2020 / Article / Fig 3

Research Article

Aliskiren Improved the Endothelial Repair Capacity of Endothelial Progenitor Cells from Patients with Hypertension via the Tie2/PI3k/Akt/eNOS Signalling Pathway

Figure 3

The effect of different concentrations of aliskiren on the in vitro function of patients’ EPCs. (a) Quantification analysis of the migration of patients’ EPCs treated with 1 μmol/L, 10 μmol/L, or 50 μmol/L aliskiren for 12 h ( vs. subjects’ EPCs without aliskiren treatment, n = 18 per group). Quantification analysis of the proliferation (b) and adhesion (c) of patients’ EPCs treated as described above ( vs. subjects’ EPCs without aliskiren treatment, n = 18 per group). hpf = high-power field.
(a)
(b)
(c)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.